Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H23NO3.ClH |
| Molecular Weight | 349.852 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC(=CC=C1)C(=O)CCN[C@@H](C)[C@H](O)C2=CC=CC=C2
InChI
InChIKey=JMUPNNYLJGSMPK-JPJJPTBZSA-N
InChI=1S/C19H23NO3.ClH/c1-14(19(22)15-7-4-3-5-8-15)20-12-11-18(21)16-9-6-10-17(13-16)23-2;/h3-10,13-14,19-20,22H,11-12H2,1-2H3;1H/t14-,19-;/m0./s1
| Molecular Formula | C19H23NO3 |
| Molecular Weight | 313.3908 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
32 mg 3 times / day multiple, oral Higher than recommended Dose: 32 mg, 3 times / day Route: oral Route: multiple Dose: 32 mg, 3 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Disc. AE: Nausea, Vomiting... AEs leading to discontinuation/dose reduction: Nausea (3.3%) Sources: Vomiting (3.3%) |
24 mg 3 times / day multiple, oral Recommended Dose: 24 mg, 3 times / day Route: oral Route: multiple Dose: 24 mg, 3 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
Disc. AE: Taste loss, Myocardial infarction... AEs leading to discontinuation/dose reduction: Taste loss (4.3%) Sources: Myocardial infarction (4.3%) |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Nausea | 3.3% Disc. AE |
32 mg 3 times / day multiple, oral Higher than recommended Dose: 32 mg, 3 times / day Route: oral Route: multiple Dose: 32 mg, 3 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
| Vomiting | 3.3% Disc. AE |
32 mg 3 times / day multiple, oral Higher than recommended Dose: 32 mg, 3 times / day Route: oral Route: multiple Dose: 32 mg, 3 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
| Myocardial infarction | 4.3% Disc. AE |
24 mg 3 times / day multiple, oral Recommended Dose: 24 mg, 3 times / day Route: oral Route: multiple Dose: 24 mg, 3 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
| Taste loss | 4.3% Disc. AE |
24 mg 3 times / day multiple, oral Recommended Dose: 24 mg, 3 times / day Route: oral Route: multiple Dose: 24 mg, 3 times / day Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effects of oxyfedrine on regional myocardial blood flow in patients with coronary artery disease. | 1991-12 |
|
| Pulmonary and systemic circulatory effects and -adrenergic selectivity of hexoprenaline, salbutamol, oxyfedrine, and isoproterenol. | 1971-07 |
|
| [Stimulation of adrenergic beta-receptors in the heart of normal and reserpinized guinea pigs by oxyfedrine]. | 1969-09 |
|
| [The management of angina pectoris using Ildamen, a new coronary- and cardiac-active substance, in a double-blind study]. | 1967-09-10 |
Patents
Sample Use Guides
Oral
Myocardial infarction, Angina pectoris
Adult: 8-24 mg tid.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14521236
Oxyfedrine was tested in vitro against 471 strains of bacteria from two Gram positive and fourteen Gram negative genera. The minimum inhibitory concentration (MIC) of oxyfedrine was determined by agar dilution method, which ranged from 50-200 ug/ml in most of the strains, while some strains were inhibited at even lower concentrations.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:28:37 GMT 2025
by
admin
on
Mon Mar 31 18:28:37 GMT 2025
|
| Record UNII |
63CF9XK7DA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
||
|
NCI_THESAURUS |
C48149
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C77154
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | |||
|
DTXSID0048632
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | |||
|
63CF9XK7DA
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL1651913
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | |||
|
100000085492
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | |||
|
5489012
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | |||
|
236758
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | RxNorm | ||
|
240-696-5
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | |||
|
16648-69-4
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
SUB03586MIG
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | |||
|
16777-42-7
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | |||
|
m8331
Created by
admin on Mon Mar 31 18:28:37 GMT 2025 , Edited by admin on Mon Mar 31 18:28:37 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |